Abstract
The single most important development in clinical cancer markers since the early 1970s, when carcinoembryonic antigen (CEA) was approved by the Food and Drug Administration, is the approval of a prostate-specific antigen (PA or PSA) as a cancer-marker test for adenocarcinoma of the prostate in 1985. In fact, whatever CEA can do for gastrointestinal cancer, PSA can do, and do it better, for prostate cancer. The clinical application of PSA in diagnosis, prognosis, and monitoring of prostate cancer is the subject of this chapter. Basic characteristics of this marker of prostate cancer also will be reviewed. Reviews of similar topic are available elsewhere (Wang et al., 1982; Chu, 1985, 1990; Chu and Murphy, 1986; Brawer and Lange, 1989; Catalona et al., 1989; Killian and Chu, 1990). It should be noted that PSA is not a neoantigen of prostate cancer or a prostate cancer specific antigen; rather, it is expressed equally, but exclusively, by normal, benign hyperplastic and cancerous prostate glands (Wang et al., 1979; Papsidero et al., 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ablin, R. J., P. Bronson, W. A. Soanes, and E. Witebsky (1970), J. Immunol. 104,1329–1339.
Ahmann, F. R. and R. B. Schifman (1987), J. Urol. 137, 431–434.
Anderson, S. and N. R. Dunnick (1989), Invest. Radiol. 24,257–259.
Ban, Y., M. C. Wang, K. W. Watt, R. M. Loor, and T. M. Chu (1984), Biochem. Biophys. Res. Commun. 123,482–488.
Barak, M., Y. Mecz, A. Lurie, and N. Gruener (1989a), J. Lab. Clin. Med. 113, 598–603.
Barak, M., Y. Mecz, A. Lurie, and N. Gruener (1989b), Oncology 46, 375–377.
Brawer, M. R. and P. H. Lange (1989), Urology 33, S11–S16.
Buamah, P. K., P. Johnson, and A. W. Skiller (1988), Br. J. Urol. 62, 581–583.
Catalona, W. J., D. S. Coffey, and J. Karr, eds. (1989), Clinical Aspects of Pros-tate Cancer: Assessment of New Diagnostic and Management Procedures, Elsevier, New York.
Catalona, W. J., D. S. Smith, T. L. Ratliff, K. M. Dodds, D. E. Copien, J. J. Yuan, J. A. Petros, and G. L. Andriole (1991), N. Engl. J. Med. 324, 1156–1161.
Caty, A., P. Gosselin, J. Cazin, J. M. Dehaut, and L. Adenis (1988), Am. J. Clin. Oncol. 11, S63—S64.
Chu, T. M. (1985), in Monoclonal Antibodies in Cancer (Sell, S. S. and R. A. Reisfeld, eds.), Humana, Clifton, NJ, pp. 309–324.
Chu, T. M. (1990), in Immunodiagnosis of Cancer (Mercer, D. W. and R. Herberman, eds.), Marcel Dekker, New York, pp. 339–356.
Chu, T. M. and G. P. Murphy (1986), Urology 27,487–491.
Chu, T. M., E. Kawinski, N. Hibi, G. Croghan, J. Wiley, C. S. Killian, and D. Corral (1989), J. Urol. 141,152–156.
Cooner, W. H., B. R. Mosley, C. L. Rutherford, J. H. Beard, H. S. Pond, N. B. Bass, and W. J. Terry (1988), J. Urol. 139, 758–761.
Dube, J. Y., D. Gaudreault, and R. Tremblay (1989), Andrologia 21,136–139.
Ercole, C. J., P. H. Lange, M. Mathiesen, R. K. Chiou, P. K. Reddy, and R. L. Vessella (1987), J. Urol. 138,1181–1184.
Ferro, M. A., I. Barnes, J. B. Roberts, and P. J. Smith (1987), Br. J. Urol. 60, 69–73.
Ferro, M., D. Gillatt, M. Symes, and P. J. Smith (1989), Urology 34,135–138.
Flocks, R. H., V. C. Urich, C. A. Patel, and J. M. Optiz (1960), J. Urol. 84, 134–135.
Ford, T. F., D. Butcher, J. R. W. Masters, and M. C. Parkinson (1985) Br. J. Urol. 57, 50–55.
Guillet, J., C. Role, A. T. Duc, and H. Francis (1988), Am. J. Clin. Oncol,11 S61–S62.
Hara, M., Y. Koyanagi, T. Inoue, and T. Fukuyama (1971), Jpn. J. Leg. Med. 25, 322–324.
Henttu, P. and P. Vihko (1989), Biochem. Biophys. Res. Commun. 160, 903–910.
Killian, C. S. and T. M. Chu (1990), Cancer Invest. 8, 27–37.
Killian, C. S., F. P. Vargas, and T. M. Chu (1988), Clin. Chem. 34, 1296.
Killian, C. S., L. J. Emrich, F. P. Vargas, N. Yang, M. C. Wang, R. Priore, G. P. Murphy, and T. M. Chu (1986), J. Natl. Cancer Inst. 76,179–185.
Kuriyama, M., M. C. Wang, C. L. Lee, L. D. Papsidero, C. S. Killian, H. Inaji, N. S. Slack, G. P. Murphy, and T. M. Chu (1981), Cancer Res. 41, 3874–3876.
Kuriyama, M., M. C. Wang, L. D. Papsidero, C. S. Killian, T. Shimano, L. A. Valenzuela, T. Nishiura, G. P. Murphy, and T. M. Chu (1980), Cancer Res. 40, 4658–4662.
Landmann, C. and R. Hunig (1989), Int. J. Radiat. Oncol. Biol. Phys. 17, 1073–1076.
Lange, P. H., C. J. Ercole, D. J. Lightner, E. E. Fraley, and R. Vessella (1989), J. Urol. 141, 873–879.
Lee, F., S. T. Pederson, L. Meilsman, D. B. Siders, P. Littrup, R. P. Don, and F. J. Pauli (1988), Int. J. Radiat. Oncol. Biol. Phys. 15,1453–1459.
Lee, F., S. T. Pederson, P. Littrup, R. D. McLeary, T. A. McHigh, A. P. Smid, P. J. Stella, and G. S. Borlaza (1989), Radiology 170, 29–32.
Lilja, H. (1988), Scand J. Clin. Lab. Invest. Suppl. 191,13–20.
Lundwall, A. (1989), Biochem. Biophys. Res. Commun. 161,1151–1159.
Maatman, T. J. (1989), J. Uro1. 141,1378–1380.
Meyers, F. J., S. J. Denardo, D. Macey, R. D. White, and M. Unger (1989), Prostate 14, 209–220.
Nadji, M., S. Z. Tabei, A. Castro, T. M. Chu, M. C. Wang, G. P. Murphy, and A. R. Morales (1981), Cancer 48,1229–1232.
Oesterling, J. E., D. W. Chan, J. I. Epstein, A. W. Kimball, D. J. Bruzek, R. C. Rock, C. B. Brendler, and P. C. Walsh (1988), J. Urol. 139, 766–772.
Papsidero, L. D., M. C. Wang, L. A. Valenzuela, G. P. Murphy, and T. M. Chu (1980), Cancer Res. 40, 2428–2432.
Papsidero, L. D., G. A. Croghan, J. Asirwatham, J. Gaeta, P. Abenoza, L. En-glander, and L. Valenzuela (1985), Am. J. Pathol. 121,451–454.
Papsidero, L. D., G. A. Croghan, M. C. Wang, M. Kuriyama, E. A. Johnson, L. A. Valenzuela, and T. M. Chu (1983), Hybridoma 2,139–147.
Papsidero, L. D., M. Kuriyama, M. C. Wang, J. S. Horoszewicz, S. S. Leong, L. A. Valenzuela, G. P. Murphy, and T. M. Chu (1981), J. Natl. Cancer Inst. 66, 37–44.
Riegman, P. H., R. J. Ulietstra, J. A. van der Korput, J. C. Romijn, and J. Trapman (1989), FEBS Lett. 247,123–126.
Sensabaugh, G. F. (1978), J. Forensic Sci. 23,106–115.
Shirbiny, A. M., T. Nielson, and H. N. Pawar (1990), Urology 35,88–92.
Stamey, T. A. and J. N. Kabalin (1989), J. Urol. 141,1070–1075.
Stamey, T. A., J. N. Kabalin, and M. Ferrai (1989), J. Urol. 141,1084–1087.
Wang, M. C., R. M. Loor, S. L. Li, and T. M. Chu (1983), IRCS Med. Sci. 11, 327–328.
Wang, M. C., L. Valenzuela, G. P. Murphy, and T. M. Chu (1979), Invest. Urol. 17,159–163.
Wang, M. C., M. Kuriyama, L. D. Papsidero, R. M. Loor, L. A. Valenzuela, G. P. Murphy, and T. M. Chu (1982), in Methods of Cancer Research vol. 19 (Busch, H., and L. C. Yeoman, eds.), Academic, New York, pp. 179–197.
Watt, K. W. K., P. J. Lee, T. M’ Timkulu, W. P. Chan, and R. M. Loor (1986), Proc. Natl. Acad. Sci. USA 83, 3166–3170.
Weber, J. P., J. E. Oesterling, C. A. Peters, A. W. Partin, D. W. Chan, and P. W. Walsh (1989), J. Uro1. 141, 987–992.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chu, T.M. (1992). Prostate-Specific Antigen. In: Sell, S. (eds) Serological Cancer Markers. Contemporary Biomedicine, vol 11. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0401-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0401-5_5
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6745-4
Online ISBN: 978-1-4612-0401-5
eBook Packages: Springer Book Archive